I

Century Therapeutics
D

IPSC

2.30000
USD
0.02
(0.88%)
مغلق
حجم التداول
28,664
الربح لكل سهم
-2
العائد الربحي
-
P/E
-7
حجم السوق
201,032,215
المقالات

العنوان: Century Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.